Funder
Key Research and Development Program of Heilongjiang
Reference23 articles.
1. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial;Zhang;Lancet Infect. Dis.,2021
2. Safety and efficacy of NVX-CoV2373 covid-19 vaccine;Heath;N. Engl. J. Med.,2021
3. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N. Engl. J. Med.,2020
4. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021
5. Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19;Sadoff;N. Engl. J. Med.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献